Klotho’s role in some patients with Alzheimer’s disease revealed?

Last Updated on

April 24, 2020 – The klotho gene is named after the fanciful Greek goddess of destiny Clotho who turns the string of life known to be related with longer life and improved cognizance. In modern biology, allelic variants of the klotho gene in fact have been associated with long life span. Klotho seems also related to a defensive capacity against psychological debilitations and Alzheimer’s disease (AD) in people conveying variants of the APOE4 gene that predispose individuals to a higher risk for the development of AD, a recent study from Stanford University, published online April 13 in JAMA. Neurology, has found.

Individuals who are heterozygous (i.e., they are carrying one copy out of two) for a particular klotho allelic variant known as klotho-VS, estimated to be about 25% of the population, produce increased serum levels of the klotho protein, which is associated with protective effects on healthy aging and longevity compared with those with no or two (i.e., being homozygous for this variant) klotho-VS alleles. Previous observational studies indicated that patients carrying certain forms of the APOE4 gene were at heightened genetic susceptibility for development of dementia along with heightened susceptibility  to the detrimental effects of various lifestyle-related risk factors, mostly because of varying degrees of amyloid bild-up in the brain (i.e., cerebrum). As recently as 2019 it was found that people carrying the APOE4 gene who had a heterozygous klotho-VS status had less amyloid in the cerebrum.

These observations led to the questions if patients with a heterozygous klotho-VS status could be protected from developing neurodegenerative diseases, such as AD, for example, and whether patients who are known to carr the APOE4 gene could be candidates for remedy of their future danger of development of AD by boosting pathways identified to dependent of klotho.

In an attempt to answer at least some of the aspects of these questions, the authors of the present study investigated 25 datasets of people with hereditary data accessible on the APOE4 and klotho genotypes. Thus, the researchers analyzed these independent datasets from case-control, family-based, and longitudinal Alzheimer’s cohorts. The risk of developing mild cognitive impairment or Alzheimer’s was evaluated through competing risks regression under a case-control design. Associations with beta-amyloid, measured from cerebrospinal fluid (CSF) or brain positron emission tomography (PET), were evaluated using linear regression and mixed-effects modeling.

Participants were men and women aged 60 years and older who were non-Hispanic and of Northwestern European ancestry and had been diagnosed as being cognitively normal or having mild cognitive impairment or Alzheimer’s. The sample included 20,928 participants in case-control studies, 3008 in conversion studies, 556 in beta-amyloid CSF regression analyses, and 251 in PET regression analyses. Results showed that individuals who were heterozygous for the klotho-VS gene had a reduced risk for Alzheimer’s in those carrying APOE4 (odds ratio [OR], 0.75; 95% confidence interval [CI], 0.67 – 0.84) among the whole population aged over 60 years. This was more prominent in those aged 60 to 80 years (OR, 0.69; 95% CI, 0.61 – 0.79). In addition, control participants carrying APOE4 with klotho-VS heterozygosity were at reduced risk of converting to mild cognitive impairment or Alzheimer’s (hazard ratio, 0.64; 95% CI, 0.44 – 0.94). Further, in control participants who carried APOE4 and were aged 60 to 80 years, klotho-VS heterozygosity was associated with higher beta-amyloid in CSF (correlating to lower levels in the brain) and lower beta-amyloid on PET scans.

In contrast, however, klotho-VS status had no association with outcome in individuals who did not carry APOE4 .

The outcomes of this research are intriguing and propose new pathways for Alzheimer’s exploration. For the moment, these outcomes will help with guiding individuals who are known to carry  the APOE4 gene in therapeutic approaches. The research also opens new questions as to why a few people with the APOE4 gene never develop AD and whether heterozygosity in klotho-VS status could be the crucial determent in these clinical phenotype.

See a short sequence on some molecular events around amyloid in AD-affected brains which may be influenced by klotho-VS status:

Print Friendly, PDF & Email

 

 

Tags: , , , , , , , ,
About the Author
Joseph Gut - thasso Ph.D.; Professor in Pharmacology and Toxicology. Senior expert in theragenomic and personalized medicine and individualized drug safety. Senior expert in pharmaco- and toxicogenetics. Senior expert in human safety of drugs, chemicals, environmental pollutants, and dietary ingredients.

Your opinion

Comment

@peepso_user_32129(Geetha) It seems to be an interesting post. My father is suffering from Alzheimer’s disease for nearly ten years. I came to know about popular neurologist in Chennai through the site https://www.drgbalamurali.com/. The study mentioned above offers some interesting results.
preview thumbnail
Dr.G.Balamurali, Senior Spine Consultant & Best Neurology Specialist in Chennai. Internationally Trained Neuro Specialist With 15 Years Experience In UK.
3 weeks ago 3 weeks ago

thasso: conditions

thasso: newest tweets

thasso: recent comments

thasso post: magazine

View my Flipboard Magazine.

thasso: categories

thasso: archives

thasso: simple chat

You must be a registered user to participate in this chat.

  • Scientists identify gene linked to thinness that may help resist weight gain May 21, 2020
    While others may be dieting and hitting the gym hard to stay in shape, some people stay slim effortlessly no matter what they eat. In a study publishing May 21 in the journal Cell, researchers use a genetic database of more than 47,000 people in Estonia to identify a gene linked to thinness that may […]
  • Tracking the COVID-19 pandemic in Australia using genomics May 21, 2020
    Using genome sequencing to identify genetic mutations in SARS-CoV-2 cases in Victoria, researchers have identified clusters and transmission networks which has helped limit the spread of the virus, painting an important picture of transmission in Victoria.
  • COVID-19 study looks at genetics of healthy people who develop severe illness May 21, 2020
    To help unravel the mysteries of COVID-19, scientists are sequencing the DNA of young, healthy adults and children who develop severe illness despite having no underlying medical problems. The researchers are looking for genetic defects that could put certain individuals at high risk of becoming severely ill from the novel coronavirus.
  • Scientists discover more than 200 genetic factors that cause heart arrhythmia May 21, 2020
    Hundreds of new links have been found between people's DNA and the heart's electrical activity, according to a study of almost 300,000 people led by researchers at Queen Mary University of London and the Broad Institute of MIT and Harvard.
  • Weight loss surgery may alter gene expression in fat tissue May 21, 2020
    Altered gene expression in fat tissue may help explain why individuals who have regained weight after weight loss surgery still experience benefits such as metabolic improvements and a reduced risk of type 2 diabetes. The findings come from a study published in the Journal of Internal Medicine.
  • New studies reveal extent and risks of laughing gas & stimulant abuse among young people May 23, 2020
    In one study, researchers from Turkey reported increasing stimulant use among medical students approaching their final exams, despite the substantial risks to their health. In the second study, researchers from the Netherlands detailed the neurological outcomes associated with recreational use of laughing gas (nitrous oxide), suggesting that, for some individuals, permanent neurological damage can occur.
  • Sleep-wake disturbances can predict recurrent events in stroke survivors May 23, 2020
    The study, conducted in Switzerland, found that having multiple sleep-wake disturbances such as sleep-disordered breathing, extreme long or short sleep duration, insomnia and restless leg syndrome independently and significantly increased the risk of a new cardio-cerebrovascular event in the two years following a stroke.
  • Does MRI have an environmental impact? May 23, 2020
    Researchers from Tokyo Metropolitan University have surveyed the amount of gadolinium found in river water in Tokyo. Gadolinium is contained in contrast agents given to patients undergoing medical magnetic resonance imaging (MRI) scans, and it has been shown in labs to become toxic when exposed to ultraviolet rays. The researchers found significantly elevated levels, particularly […]
  • New native grass species have been discovered on the Iberian Peninsula and Menorca May 22, 2020
    The new species belong to the genus Aira, delicate herbaceous plants, which enjoy their greatest diversity in the Mediterranean Region. One of them, Aira minoricensis is a native species of the siliceous sands of Menorca. The other new species is called Aira hercynica and is widely found in the area of the Iberia Peninsula which […]
  • Combinatorial screening approach opens path to better-quality joint cartilage May 22, 2020
    High-throughput platform identifies complex conditions with biomaterial compositions, and mechanical and chemical stimuli that help stem cells produce more robust cartilage.
Top